Healthcare

Infographic | Highlighting top healthcare trends

Infographic | Highlighting top healthcare trends

By

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.

Payers: High-deductible health plans don't drive positive consumer behavior

Payers: High-deductible health plans don't drive positive consumer behavior

By

As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.

How should pharma mine electronic health records as a data source?

How should pharma mine electronic health records as a data source?

By

At a time when value-based healthcare is a more common objective among stakeholders, EHR data can enable collaboration among payers, providers, health systems, and pharma manufacturers.

Five things for pharma marketers to know: Monday, February 5

Five things for pharma marketers to know: Monday, February 5

By

Opdivo hits key goal in late-stage trial; Philippines government sues Sanofi over anti-dengue vaccine; hospitals reach capacity amid record flu season.

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

By

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

The race is on: Amazon, Buffett, and JPMorgan enter healthcare

The race is on: Amazon, Buffett, and JPMorgan enter healthcare

Forget making incremental changes to the system. These three corporate giants are trying to change the model of U.S. healthcare itself.

Five things for pharma marketers to know: Tuesday, January 30, 2018

Five things for pharma marketers to know: Tuesday, January 30, 2018

By

Amazon, Berkshire Hathaway, and JPMorgan team up to form a healthcare company; Takeda's Zika vaccine receives FDA fast-track status

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Five things for pharma marketers to know: Friday, January 5, 2018

Five things for pharma marketers to know: Friday, January 5, 2018

By

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise

From working for one administration to fending off another: Planned Parenthood's Kevin Griffis

From working for one administration to fending off another: Planned Parenthood's Kevin Griffis

By

Kevin Griffis brought his experience in government and politics to Planned Parenthood at the perfect time, leading the fight to protect birth control coverage under the Trump administration and destigmatizing abortion.

Five things for pharma marketers to know: Thursday, December 28, 2017

Five things for pharma marketers to know: Thursday, December 28, 2017

By

Study: male docs earn more than female peers; new Michigan law tackles opioid crisis; study: some docs billed Medicare for most expensive patient visit type

MM&M's 5 most-read technology stories of 2017

MM&M's 5 most-read technology stories of 2017

By

Digital innovation in Japan, health-tech trends, and social media top the list.

Five things for pharma marketers to know: Tuesday, December 26, 2017

Five things for pharma marketers to know: Tuesday, December 26, 2017

By

Roche to buy Ignyta for $1.7 billion; FDA OKs Valeant eye drop for OTC sale; Kmart settles prescription drug fraud allegations

Five things for pharma marketers to know: Monday, December 18, 2017

Five things for pharma marketers to know: Monday, December 18, 2017

By

CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter's Vraylar sees positive results for bipolar depression

Five things for pharma marketers to know: Tuesday, December 5, 2017

Five things for pharma marketers to know: Tuesday, December 5, 2017

By

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

Five things for pharma marketers to know: Monday, December 4, 2017

Five things for pharma marketers to know: Monday, December 4, 2017

By

CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate

A Road Map for Your Campaign

A Road Map for Your Campaign

Only 2.6% of board members in Standard & Poor's 1,500 firms have marketing experience.

Centers for Medicare and Medicaid Services puts $900m IDIQ up for bid

Centers for Medicare and Medicaid Services puts $900m IDIQ up for bid

By

Ketchum, Ogilvy, Porter Novelli, Weber Shandwick, and FleishmanHillard are among the firms that have been awarded past Centers for Medicare and Medicaid Services IDIQ accounts.

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

By

Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.

Five things for pharma marketers to know: Wednesday, October 11, 2017

Five things for pharma marketers to know: Wednesday, October 11, 2017

By

Pfizer considers sale of its consumer healthcare business; Express Scripts moves into patient benefit management; China to speed up drug approvals

Oscar Health launches open enrollment campaign as funding is slashed for ACA ads

Oscar Health launches open enrollment campaign as funding is slashed for ACA ads

By

The health insurance startup launched a campaign this week that urges people to get covered.

Why Educating the Board about Your Latest Campaign Matters

Why Educating the Board about Your Latest Campaign Matters

What is second nature to most marketers may not be well understood by healthcare professionals who have spent their careers as physicians, researchers, or caregivers.

Why use health plan apps? To search for specialists and understand drug coverage

Why use health plan apps? To search for specialists and understand drug coverage

By

Consumers younger than the age of 45 were most likely to use an app developed by their health plan.

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

By

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

Five things for pharma marketers to know: Thursday, July 27, 2017

Five things for pharma marketers to know: Thursday, July 27, 2017

By

Generic drugmakers reportedly seeking deals; GSK to refocus R&D; Merck and AstraZeneca to test combo cancer drug

Want to Win Hispanic Patients? Get Personal

Want to Win Hispanic Patients? Get Personal

More than other patient groups, they want a deeper, ongoing relationship with caregivers.

MM&M's top 100 healthcare agencies of 2017

MM&M's top 100 healthcare agencies of 2017

Here, we profile 100 of the largest healthcare advertising agencies in North America.

Five things for pharma marketers to know: Thursday, June 22, 2017

Five things for pharma marketers to know: Thursday, June 22, 2017

By

The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement

Pharma faces its 'oh, shit' moment

Pharma faces its 'oh, shit' moment

By

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Dr. John Brownstein, Circulation

Dr. John Brownstein, Circulation

Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.